Your browser doesn't support javascript.
loading
Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis.
Ikeda, Shinya; Yamashita, Yugo; Morimoto, Takeshi; Chatani, Ryuki; Kaneda, Kazuhisa; Nishimoto, Yuji; Ikeda, Nobutaka; Kobayashi, Yohei; Ikeda, Satoshi; Kim, Kitae; Inoko, Moriaki; Takase, Toru; Tsuji, Shuhei; Oi, Maki; Takada, Takuma; Otsui, Kazunori; Sakamoto, Jiro; Ogihara, Yoshito; Inoue, Takeshi; Usami, Shunsuke; Chen, Po-Min; Togi, Kiyonori; Koitabashi, Norimichi; Hiramori, Seiichi; Doi, Kosuke; Mabuchi, Hiroshi; Tsuyuki, Yoshiaki; Murata, Koichiro; Takabayashi, Kensuke; Nakai, Hisato; Sueta, Daisuke; Shioyama, Wataru; Dohke, Tomohiro; Nishikawa, Ryusuke; Ono, Koh; Kimura, Takeshi.
Afiliación
  • Ikeda S; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Pharmacology, Shiga University of Medical Science, Otsu, Japan.
  • Yamashita Y; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Electronic address: yyamashi@kuhp.kyoto-u.ac.jp.
  • Morimoto T; Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Chatani R; Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Kaneda K; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nishimoto Y; Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
  • Ikeda N; Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
  • Kobayashi Y; Department of Cardiovascular Center, Osaka Red Cross Hospital, Osaka, Japan.
  • Ikeda S; Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kim K; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Inoko M; Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan.
  • Takase T; Department of Cardiology, Kinki University Hospital, Osaka, Japan.
  • Tsuji S; Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
  • Oi M; Department of Cardiology, Japanese Red Cross Otsu Hospital, Otsu, Japan.
  • Takada T; Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
  • Otsui K; Department of General Internal Medicine, Kobe University Hospital, Kobe, Japan.
  • Sakamoto J; Department of Cardiology, Tenri Hospital, Tenri, Japan.
  • Ogihara Y; Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
  • Inoue T; Department of Cardiology, Shiga General Hospital, Moriyama, Japan.
  • Usami S; Department of Cardiology, Kansai Electric Power Hospital, Osaka, Japan.
  • Chen PM; Department of Cardiology, Osaka Saiseikai Noe Hospital, Osaka, Japan.
  • Togi K; Division of Cardiology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan.
  • Koitabashi N; Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Hiramori S; Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
  • Doi K; Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Mabuchi H; Department of Cardiology, Koto Memorial Hospital, Higashiomi, Japan.
  • Tsuyuki Y; Division of Cardiology, Shimada General Medical Center, Shimada, Japan.
  • Murata K; Department of Cardiology, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
  • Takabayashi K; Department of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.
  • Nakai H; Department of Cardiovascular Medicine, Sugita Genpaku Memorial Obama Municipal Hospital, Obama, Japan.
  • Sueta D; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Shioyama W; Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan.
  • Dohke T; Division of Cardiology, Kohka Public Hospital, Koka, Japan.
  • Nishikawa R; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ono K; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kimura T; Department of Cardiology, Hirakata Kohsai Hospital, Hirakata, Japan.
Thromb Res ; 238: 27-36, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38653180
ABSTRACT

BACKGROUND:

Patients with unprovoked venous thromboembolisms (VTEs) can be sub-classified based on the different phenotypes using a latent class analysis (LCA), which might be useful for selecting individual management strategies.

METHODS:

In the COMMAND VTE Registry-2 database enrolling 5197 VTE patients, the current derivation cohort consisted of 1556 patients with unprovoked VTEs. We conducted clustering with an LCA, and the patients were classified into subgroups with the highest probability. We compared the clinical characteristics and outcomes among the developed subgroups.

RESULTS:

This LCA model proposed 3 subgroups based on 8 clinically relevant variables, and classified 592, 813, and 151 patients as Class I, II, and III, respectively. Based on the clinical features, we named Class I the younger, Class II the older with a few comorbidities, and Class III the older with many comorbidities. The cumulative 3-year anticoagulation discontinuation rate was highest in the older with many comorbidities (Class III) (39.9 %, 36.1 %, and 48.4 %, P = 0.02). There was no significant difference in the cumulative 5-year incidence of recurrent VTEs among the 3 classes (12.8 %, 11.1 %, and 4.0 % P = 0.20), whereas the cumulative 5-year incidence of major bleeding was significantly higher in the older with many comorbidities (Class III) (7.8 %, 12.7 %, and 17.8 %, P = 0.04).

CONCLUSION:

The current LCA revealed that patients with unprovoked VTEs could be sub-classified into further phenotypes depending on the patient characteristics. Each subclass phenotype could have different clinical outcomes risks especially a bleeding risk, which could have a potential benefit when considering the individual anticoagulation strategies. CLINICAL TRIAL REGISTRATION URL http//www.umin.ac.jp/ctr/index.htm COMMAND VTE Registry-2 Unique identifier, UMIN000044816 COMMAND VTE Registry Unique identifier, UMIN000021132.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenotipo / Tromboembolia Venosa / Análisis de Clases Latentes Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Thromb Res Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fenotipo / Tromboembolia Venosa / Análisis de Clases Latentes Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Thromb Res Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos